Home / Conferences / IQPC Biosimilar Commercialisation Summit 2019

IQPC Biosimilar Commercialisation Summit 2019 Posted 05/04/2019

IQPC Biosimilar Commercialisation Summit 2019
14‒16 May 2019
Hotel Novotel Amsterdam Schiphol Airport
Amsterdam, The Netherlands

The inaugural Biosimilars Commercialisation Summit is the only forum focused entirely on helping you speed up market access of Biosimilars.

Learn from over 20 hours of case studies detailing peer-proven techniques to help you stand out in a crowded market, broaden patient access, overcome the challenges of various regional healthcare systems and accelerate your entry into the market with efficient manufacturing and supply strategies.

Expert speakers include:
• Simon Keady, EU Market Access Lead – Biosimilars, Biogen
• Francisco Ballester, President, Latin America, Sandoz
• Don Stewart, CEO, PlantForm
• Anna Aillerie, Head of Commercial Operations, Biotechnology Business Unit, Gedeon Richter
• Sue Caleo-Naeyaert, Global Head Government Affairs, Policy and Pharmacoeconomics, Fresenius Kabi SwissBioSim
• Andreas Herrmann, CEO, Valerius Biopharma AG
• Jose Carlos Ferreyra, President, Mexican Pharmaceutical Institute
• Louis Boon, Chief Scientific Officer, Bioceros, Polpharma Group
• And Many More!

https://biosimilars.iqpc.com/